Evaluation of Continuity of Care of Children With Special Health Needs

Sponsor
IRCCS Burlo Garofolo (Other)
Overall Status
Completed
CT.gov ID
NCT05803291
Collaborator
(none)
51
1
37.2
1.4

Study Details

Study Description

Brief Summary

Children and adolescents with special health care needs represent a small but relevant subset of the pediatric population due to high costs for the health care system, risk of lower quality of care, unmet health care needs, and negative health outcomes. Coordination of care and continuity of care are essential issues of appropriate care for these patients, as showed also by the "Special Needs Kids" project, carried out in Emilia Romagna. This project showed the potential for family pediatricians (FP) in Italy to serve as care coordinators and facilitate the implementation of integrated care pathways for children with special health care needs. In Friuli-Venezia Giulia (FVG), a system of "continuity of care" for patients with special needs was developed and implemented. This system integrate hospital and community care in a network involving also FPs, General Practitioner and different actors of social and health services. The aim of this study is to prospectively evaluate the continuity of care provided to children and adolescents with special health needs residing in the FVG region.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    51 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Children With Special Health Needs. Evaluation of Continuity of Care and Integrated Hospital-territory Care Pathways in Friuli Venezia Giulia
    Actual Study Start Date :
    Sep 26, 2018
    Actual Primary Completion Date :
    Oct 31, 2021
    Actual Study Completion Date :
    Oct 31, 2021

    Outcome Measures

    Primary Outcome Measures

    1. To assess health care providers activities using the Special Needs Kids instrument [Through study completion, an average of 12 months]

      The Special Needs Kids (SpeNK)-FP instrument includes eight descriptive items aiming to collect information about the activity performed by the FP for the patients, involving the child or the family and including visit at the clinic, phone contact, ecc. In particular, SpeNK-FP evaluates: patient's clinical and social complexity on a three levels scale; requests or problems addressed; needs for care coordination; activities carried out by the FP; involvement of any other professionals in the care coordination activity; time spent for care coordination; FP's appraisal about the outcomes occurred and prevented with the care coordination activity.

    2. To assess parents' perspective on continuity of care using the Special Needs Kids Questionnaire [At 10 months after enrollment]

      The Special Needs Kids Questionnaire (SpeNK-Q) is a 20 items (with 5-point response option) questionnaire, evaluating parents' perspective about their relationship and interactions with: 1) the FP; 2) the main care coordinator; 3) the network of health care providers and services. SpeNK-Q includes two open questions aiming at identifying: 1) the person who is in charge of most of the child's health; (2) the person who coordinates the child's health care. The 5-point response option are: from "fully disagree" to "fully agree" for questions 1-7 concerning FP (lower scores indicates a worse outcome); form "never or almost never" to "always or almost always" for questions 8-20 concerning the network of health care providers and services.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Day to 17 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Subjects with special health care needs requiring continuity of care and integrated home care

    • Age between 0 to 17 years

    • Residence in FVG region

    • Outpatient, inpatient or emergency care admission at the IRCCS Burlo Garofolo hospital, Trieste, Italy

    Exclusion Criteria:

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 IRCCS Burlo Garofolo Trieste Italy 34137

    Sponsors and Collaborators

    • IRCCS Burlo Garofolo

    Investigators

    • Principal Investigator: Elisa Zanello, MSC, IRCCS materno infantile Burlo Garofolo

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    IRCCS Burlo Garofolo
    ClinicalTrials.gov Identifier:
    NCT05803291
    Other Study ID Numbers:
    • RC 17/16
    First Posted:
    Apr 7, 2023
    Last Update Posted:
    Apr 7, 2023
    Last Verified:
    Apr 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by IRCCS Burlo Garofolo

    Study Results

    No Results Posted as of Apr 7, 2023